Health NewsPIB Press Releases

Dr Bharati Pravin Pawar launches Phase-III of Thalassemia Bal Sewa Yojana

Launches Thalassemia Bal Sewa Yojana Portal and releases Standard Treatment Guidelines for Sickle Cell Anemia Disease

Dr Bharati Pravin Pawar, Union Minister of State for Health and Family Welfare launched the third phase of the Thalassemia Bal Sewa Yojana (TBSY) of the Health Ministry which is being supported by Coal India Limited as part of their Corporate Social Responsibility (CSR) initiative to commemorate World Thalassemia Day, here yesterday. She also launched the Thalassemia Bal Sewa Yojana Portal.  Shri Rajesh Bhushan, Union Health Secretary, Shri Anil Kumar Jha, Secretary, Ministry of Tribal Affairs and Dr Rajiv Bahl, Secretary, Department of Health Research were also present.

Thalassemia is an inherited blood disorder that causes a body to have less hemoglobin than normal. The Union Health Ministry has been implementing the TBSY since 2017 under the National Health Mission (NHM) and had recently completed its second phase in March 2023. The Coal India CSR-funded Hematopoietic Stem Cell Transplant (HSCT) program is a unique initiative aimed at providing a one-time cure opportunity to underprivileged Thalassemia patients who have a matched sibling donor but do not have the financial resources to cover the cost of the procedure. The program has successfully completed 356 bone marrow transplants for Thalassemia patients across 10 empanelled hospitals in India during the two phases.

Dr Bharati Pravin Pawar stated that “it is important to enhance screening of the disease, create more awareness and counselling opportunities, and also increase treatment facilities to fight blood disorders such as Thalassemia and sickle cell disease”. Urging various stakeholders to come forward and lend a helping hand for strengthening the fight against blood-related disorders, she stated that “Multi-stakeholder approach will help to mobilize nationwide support for awareness and treatment for blood-related disorders”.

Appreciating the efforts of partner Ministries and other stakeholders like CIL, she encouraged them to continue their efforts towards removing stigmas and misconceptions associated with such hereditary diseases and generating more awareness to address the knowledge gap surrounding sickle cell disease. She congratulated Coal India Limited (CIL) and Thalassemic India for joining the Union Health Ministry in launching the third phase of TBSY.

Dr Bharati Pravin Pawar launches Phase-III of Thalassemia Bal Sewa Yojana
Photo credit-Press release by PIB

Dr Pawar also released the Standard Treatment Workflow for Sickle Cell Disease on the occasion. This has been developed by ICMR. The Union Minister further highlighted the need to take advantage of various initiatives of the Union Government for the treatment of diseases like sickle cell anemia such as the e-Raktkosh portal for blood transfusion requirements and the network of over 1.5 lakh Health and Wellness Centres for treatment and diagnostic care.

Shri Rajesh Bhushan, Secretary (HFW) noted that TBSY looks at the treatment aspects of sickle cell disease. He emphasized the need for bringing the disease under the health systems approach and focus on counselling and other aspects as well. He also highlighted the need for bringing in multiple stakeholders under the initiative to spread awareness and provide counselling. He further informed that the Union Health Ministry is working on increasing the facilities for providing tertiary care to sickle cell patients across the country.

Shri Anil Kumar Jha, Secretary (MoTA) called the inauguration of the third phase of the program an important milestone towards eradicating the disease completely. He urged all stakeholders to come together and include other public and private sector organizations towards creating state-of-the-art infrastructure for the treatment of sickle cell disease.

Dr Rajiv Bahl, Secretary (DHR) stated that Thalassemia is a preventable disease if screened and treated early. He highlighted the need to increase the capacity for bone marrow transplants and noted that ICMR is working towards meeting this capacity through the support of organizations like CIL.

Dr Bharati Pravin Pawar launches Phase-III of Thalassemia Bal Sewa Yojana
Photo credit-Press release by PIB

The third phase of the program will continue to provide financial assistance for a package cost of 10 lakhs per HSCT, directly transferred from CIL to the institutions performing HSCT. The program will benefit underprivileged thalassemia patients and those with aplastic anemia, which is an irreversible condition that can be life-threatening without treatment. The program has empanelled 10 reputed hospitals across India, including AIIMS, New Delhi; CMC Vellore; Kokilaben Dhirubhai Ambani Hospital, Mumbai; MCGM Hospital, Mumbai; PGIMER, Chandigarh; Rajiv Gandhi Cancer Institute, New Delhi; SGPGI, Lucknow; Narayana Hrudayalaya, Bangalore; CMC, Ludhiana and Tata Medical Centre, Kolkata among others.

CIL has created a web portal to empower online applications for the conspire. Patients will be able to get to the development of their application from enrollment to closure in real-time through the entry. The entrance is being propelled alongside the 3rd stage of the scheme. The program is an excellent example of a successful CSR initiative that is making a real difference in the lives of thalassemia patients and their families with the hope that the third phase of the scheme will continue to bring hope and relief to thalassemia patients and their families and contribute towards building a healthier and more equitable society.

Shri Vishal Chauhan, Joint Secretary, Health Ministry, Dr Atul Goel, DGHS, Dr Anil Kumar, Addl. DDG, NBTC, Ms Renu Chaturvedi, Head, CSR, Coal India Limited, Shri Deepak Chopra, President Thalassemic India, Shri V K Khanna, Vice-President, Thalassemic India, Ms Shobha Tuli, Secretary, Thalassemic India, Principal Secretary and Mission Directors of States/UTs and senior officials of the Health Ministry were also present on the occasion.

Disclaimer: This is an official press release by pib.

Back to top button